Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge
Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge

In today's Pharmaceutical Executive Daily, AlzeCure Pharma announces a collaboration with QuantumCell ApS worth more than $2.2 billion for global rig…

4 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program
Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program

In today's Pharmaceutical Executive Daily, FDA selects seven companies for its new PreCheck Pilot Program, Kirsten Whipple examines how the concept o…

4 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics
Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics

In today's Pharmaceutical Executive Daily, a pharma M&A roundup covers Ipsen's up to $1.75 billion acquisition of Kartos Therapeutics and Zymeworks' …

4 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

4 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will l…

4 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

In today's Pharmaceutical Executive Daily, the FDA announces Operation TrialBlazer, a pilot program aimed at cutting early-stage clinical trial timel…

4 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion
Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

In today's Pharmaceutical Executive Daily, AbbVie announces a $10.9 billion agreement to acquire Apogee Therapeutics, adding a suite of clinical-stag…

4 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

In today's Pharmaceutical Executive Daily, an FDA advisory committee votes unanimously in favor of the benefit-risk profile of Moderna's investigatio…

4 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive
Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

In today's Pharmaceutical Executive Daily, Biogen announces its second acquisition of 2026, a deal worth up to $1 billion for private immunology biot…

5 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs
Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs

In today's Pharmaceutical Executive Daily, FDA staff release briefing documents flagging evidence gaps in Moderna's mRNA flu vaccine, a pharma roundu…

5 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us